Adaptin Bio (APTN) Accounts Payables (2022 - 2026)

Adaptin Bio has disclosed Accounts Payables across 5 years of filings, most recently posting $1.7 million for Q2 2026.

• In Q2 2026, Accounts Payables rose 151.14% year-over-year to $1.7 million; the TTM figure through Jun 2026 stood at $1.7 million (up 151.14% YoY), while the FY2025 annual figure was $1.5 million, up 11.09% from the prior year.
• Accounts Payables came in at $1.7 million for Q2 2026 at Adaptin Bio, up from $1.4 million in the prior quarter.
• In the past five years, Accounts Payables ranged from a high of $1.7 million in Q2 2026 to a low of $58.0 in Q4 2023.
• Average Accounts Payables over 5 years is $650020.8, with a median of $327057.0 recorded in 2025.
• Year-over-year, Accounts Payables tumbled 99.54% in 2023 and jumped 2346591.38% in 2024.
• Over 5 years, Accounts Payables stood at $12500.0 in 2022, then plunged by 99.54% to $58.0 in 2023, then jumped by 2346591.38% to $1.4 million in 2024, then gained by 11.09% to $1.5 million in 2025, then increased by 10.71% to $1.7 million in 2026.
• Per Business Quant data, the three most recent Accounts Payables figures were $1.7 million in Q2 2026, $1.4 million in Q1 2026, and $1.5 million in Q4 2025.